---
title: "AD109 (aroxybutynin-atomoxetine) in Obstructive sleep apnea: Disease description"
description: "Formulary evidence on AD109 (aroxybutynin-atomoxetine, Oxnimbi) in Obstructive sleep apnea: Disease description. Covers Definition and etiology; Epidemiology; Natural history, survival, and mortality; Pathophysiology; Diagnosis; Clinical presentation - signs and symptoms; 2 further headings. 117 evidence topics quoted from 82 sources."
canonical: "https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/product-information-and-disease-description/disease-description"
published: "2026-11-18T10:43:47-05:00"
modified: "2026-11-18T10:43:47-05:00"
---

# AD109 (aroxybutynin-atomoxetine) in Obstructive sleep apnea: Disease description

<a id="heading-2.2.1"></a>

## 2.2.1 Disease Description

- [Definition and etiology](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/product-information-and-disease-description/definition-and-etiology)

- [Epidemiology](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/product-information-and-disease-description/epidemiology)

- [Natural history, survival, and mortality](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/product-information-and-disease-description/natural-history-survival-and-mortality)

- [Pathophysiology](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/product-information-and-disease-description/pathophysiology)

- [Diagnosis](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/product-information-and-disease-description/diagnosis)

- [Clinical presentation - signs and symptoms](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/product-information-and-disease-description/clinical-presentation-signs-and-symptoms)

- [Long-term morbidity](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/product-information-and-disease-description/long-term-morbidity)

- [Disease burden](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/product-information-and-disease-description/disease-burden)

## Related pages
- [AD109 (aroxybutynin-atomoxetine): Obstructive sleep apnea](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea) · [Markdown](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea.md)
- [AD109 (aroxybutynin-atomoxetine) in Obstructive sleep apnea: Terms and abbreviations](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/terms-and-abbreviations.md)
- [AD109 (aroxybutynin-atomoxetine): Obstructive sleep apnea](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/executive-summary) · [Markdown](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/executive-summary.md)
- [AD109 (aroxybutynin-atomoxetine) in Obstructive sleep apnea: Product information and disease description](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/product-information-and-disease-description.md)
- [AD109 (aroxybutynin-atomoxetine) in Obstructive sleep apnea: Clinical evidence](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/clinical-evidence.md)
- [AD109 (aroxybutynin-atomoxetine) in Obstructive sleep apnea: Economic information and modeling report](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/economics) · [Markdown](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/economics.md)
- [AD109 (aroxybutynin-atomoxetine) in Obstructive sleep apnea: References](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/references) · [Markdown](https://www.evicenter.com/drugs/ad109--obstructive-sleep-apnea/references.md)
